EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: Evidence for a PPAR-γ-dependent mechanism

Kidney International

Volumn 67, Issue 3, 2005, Pages 867-874

  Li, Hang ^b   Ruan, Xiong Z ^a   Powis, Stephen H ^b   Fernando, Ray ^b   Mon, Wint Y ^b   Wheeler, David C ^b   Moorhead, John F ^b   Varghese, Zac ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE

Author keywords

NF B; PPAR ; 3 polyunsaturated fatty acids

Indexed keywords

2,2 BIS(4 GLYCIDYLOXYPHENYL)PROPANE; DOCOSAHEXAENOIC ACID; ETHER DERIVATIVE; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; 2,2-BIS(4-GLYCIDYLOXYPHENYL)PROPANE; EPOXIDE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; KIDNEY TUBULE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; CELL CULTURE; METABOLISM; PHYSIOLOGY;

CELLS, CULTURED; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EPOXY COMPOUNDS; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; NF-KAPPA B; PPAR GAMMA;

EID: 20844440063     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00151.x     Document Type: Article

References (35)

1. SIAMOPOULOS AP: Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21:495-505, 2002
2. BELLUZZI A: N-3 fatty acids for the treatment of inflammatory bowel diseases. Proc Nutr Soc 61:391-395, 2002
3. CLARK WF, PARBTANI A, NAYLOR CD, et al: Fish oil in lupus nephritis: Clinical findings and methodological implications. Kidney Int 44:75-86, 1993
4. DE CATERINA R, CAPRIOLI R, GIANNESSI D, et al: n-3 fatty acids reduce proteinuria in patients with chronic glomerular disease. Kidney Int 44:843-850, 1993
5. BARCELLI UO, MIYATA J, ITO Y, et al: Beneficial effects of polyunsaturated fatty acids in partially nephrectomized rats. Prostaglandins 32:211-219, 1986
6. CHANDRASEKAR B, FERNANDES G: Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis. Biochem Biophys Res Commun 200:893-898, 1994
7. CLARK WF, PARBTANI A, PHILBRICK DJ, et al: Chronic effects of omega-3 fatty acids (fish oil) in a rat 5/6 renal ablation model. J Am Soc Nephrol 1:1343-1353, 1991
8. GOLDSTEIN DJ, WHEELER DC, SANDSTROM DJ, et al: Fish oil ameliorates renal injury and hyperlipidemia in the Milan normotensive rat model of focal glomerulosclerosis. J Am Soc Nephrol 6:1468-1475, 1995
9. RAHMAN MA, SAUTER DC, YOUNG MR: Effects of dietary fish oil on the induction of experimental membranous nephropathy in the rat. Lab Invest 64:371-376, 1991
10. DONADIO JV, JR., GRANDE JP, BERGSTRALH EJ, et al: The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J Am Soc Nephrol 10:1772-1777, 1999
11. DONADIO JV, JR., LARSON TS, BERGSTRALH EJ, et al: A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy. J Am Soc Nephrol 12:791-799, 2001
12. DONADIO JV, JR., BERGSTRALH EJ, OFFORD KP, et al: A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N Engl J Med 331:1194-1199, 1994
13. GRANDE JP, DONADIO JV, JR.: Dietary fish oil supplementation in IgA nephropathy: A therapy in search of a mechanism? Nutrition 14:240-242, 1998
14. NATH KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992
15. EDDY AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5:1273-1287, 1994
16. DANOFF TM: Chemokines in interstitial injury. Kidney Int 53:1807-1808, 1998
17. VIEDT C, DECHEND R, FEI J, et al: MCP-1 induces inflammatory activation of human tubular epithelial cells: Involvement of the transcription factors, nuclear factor-kappaB and activating protein-1. J Am Soc Nephrol 13:1534-1547, 2002
18. ISSEMANN I, GREEN S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-650, 1990
19. ESCHER P, WAHLI W: Peroxisome proliferator-activated receptors: Insight into multiple cellular functions. Mutat Res 448:121-138, 2000
20. LEHMANN JM, MOORE LB, SMITH-OLIVER TA, et al: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator- activated receptor gamma (PPAR gamma). J Biol Chem 270:12953-12956, 1995
21. JIANG C, TING AT, SEED B: PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86, 1998
22. KLIEWER SA, SUNDSETH SS, JONES SA, et al: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94:4318-4323, 1997
23. VANDEN HEUVEL JP: Peroxisome proliferator-activated receptors: A critical link among fatty acids, gene expression and carcinogenesis. J Nutr 129:5758-5808, 1999
24. Xu HE, LAMBERT MH, MONTANA VG, et al: Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3:397-403, 1999
25. RYAN MJ, JOHNSON G, KIRK J, et al: HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int 45:48-57, 1994
26. GRANDE JP, WALKER HJ, HOLUB BJ, et al: Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo. Kidney Int 57:1027-1040, 2000
27. REMUZZI G, RUGGENENTI P, BENIGNI A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
28. WANG Y, CHEN J, CHEN L, et al: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8:1537-1545, 1997
29. MANITIUS J, SULIKOWSKA B, Fox J, et al: The effect of dietary enrichment with fish-oil on urinary excretion of N-acetyl-beta-d-glucosaminidase and renal function in proteinuric patients with primary glomerulopathies. Int Urol Nephrol 29:489-495, 1997
30. KEES-FOLTS D, SADOW JL, SCHREINER GF: Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 45:1697-1709, 1994
31. LEE TH, MENCIA-HUERTA JM, SHIH C, et al: Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 74:1922-1933, 1984
32. ENDRES S, GHORBANI R, KELLEY VE, et al: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265-271, 1989
33. POYNTER ME, DAYNES RA: Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Bio Chem 273:32833-32841, 1998
34. WRIGHT HM, CLISH CB, MIKAMI T, et al: A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. J Biol Chem 275:1873-1877, 2000
35. DELERIVE P, DE BOSSCHER K, BESNARD S, et al: Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-I. J Biol Chem 274:32048-32054, 1999